| ASTRAZENECA PLC DL-,25 |
| Großbritannien |
| Gesundheit |
| GB0009895292 / 886455 |
| ZEG (Frankfurt) / AZN (NYSE) |
| FRA:ZEG, ETR:ZEG, ZEG:GR, NYSE:AZN |
| FTSE100 |
| https://www.astrazeneca.c.. |
|
AstraZeneca PLC is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes prescription medicines. AstraZeneca PLC focuses on major therapeutic areas including oncology, rare diseases, cardiovascular, renal and m..
>Volltext.. |
| 236819.47 Mio. EUR |
| 260779.57 Mio. EUR |
| 54447.54 Mio. EUR |
| 17818.48 Mio. EUR |
| 9264.33 Mio. EUR |
| 5.98 EUR |
| 28921.12 Mio. EUR |
| 4389.44 Mio. EUR |
| 12410.88 Mio. EUR |
| 0.16 |
| 4.3% |
| 20.71% |
| 2.75 EUR |
| - |
| 1.88% |
| 06.08.26 - 0.92697€ 19.02.26 - 1.824042€ >weitere anzeigen... |
| - |
| ASTRAZENECA, ASTRA ZENECA |
| 30.10.26 |
|